Table 1

Characteristics and birth conditions of the infants included in the study and characteristics of bronchiolitis hospitalization
Eligible infants (N=463)
Age at hospitalization (months) Mean (SD) 3.3 (2.7)
Median (Q1 – Q3) 2.5 (1.3 – 5.0)
Min – Max 0.3 – 12.0
Sex – n (%) Male 254 (54.9)
Siblings – n (%) 0 120 (25.9)
1 or more 335 (72.4)
Multiple pregnancies – n (%) 36 (7.8)
Gestational age – n (%) Infant with CHD (N=28) – n (%)
Full-term 23 (82.1)
33-36 wGA 2 (7.1)
≤ 32 wGA 3 (10.7)
Infant without CHD (N=435) – n (%)
Full-term 309 (71.0)
33-36 wGA 69 (15.9)
≤ 32 wGA 57 (13.1)
Chronic lung disease – n (%) 31 (6.7)
Family’s allergy history – n (%) 120 (25.9)
Hospitalization in neonatal unit – n (%) 147 (31.8)
Duration of hospitalization (days) Mean (SD) 6.6 (4.6)
Median (Q1 – Q3) 5.0 (4.0 – 8.0)
Min – Max 1.0 – 46.0
Hospitalization department (%) General pediatrics (only) 73.9
Intensive care department 14.3
Neonatal unit (but not intensive care) 7.1
Other department 4.8
RSV test (%) 91.8
RSV-positive 72.0
Medications used (N=330)a (%) Bronchodilators 57.3
Antibiotics 57.3
Corticosteroids 31.5
Anti-reflux treatment 20.0
Non-medicated treatments (N=455) (%) Respiratory physiotherapy 95.6
Infusion or parenteral nutrition 37.6
Oxygen therapy 64.6
Enteral nutrition 29.9
Non-invasive ventilation 13.0
Assisted ventilation 4.8

a Several medicated or non-medicated treatments could be reported.

Lapillonne et al.

Lapillonne et al. BMC Pediatrics 2012 12:171   doi:10.1186/1471-2431-12-171

Open Data